COVID-19 Re-Enfekte Hastada Periorbital Herpes Zoster Duplex Bilateralis Birlikteliği
Öz
Anahtar Kelimeler
Kaynakça
- 1-Sachdeva M, Gianotti R, Shah M, et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. J Dermatol Sci 2020; 98: 75-81.
- 2-Elsaie ML, Nada HA. Herpes zoster (shingles) complicating the course of COVID19 infection. J Dermatol Treat 2020; 12:1-3.
- 3-Saati A, Al-Husayni F, Malibari AA, et al. Herpes zoster co-infection in an immunocompetent patient with COVID-19. Cureus 2020; 12: e8998.
- 4-Tartari F, Spadotto A, Zengarini C, Zanoni R, et al. Herpes zoster in COVID-19-positive patients. International Journal of Dermatology; 2020; 59:1028-1029.
- 5- I. Staikov, N. Neykov, B. Marinovic, et al. Herpes zoster as a systemic disease Clinics in Dermatology, 2014; 32:424–429.
- 6- Jiang M, Guo Y, Luo Q, et al. T-cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of Coronavirus Disease 2019. J Infect Dis. 2020;2 22:198–202.
- 7- Lee SY, Choi YS, Yu HJ, Son SJ. A case of bilateral herprs zoster. Korean J Dermatol. 1994;32:1119–1122.
- 8-Ferreira ACA de F. Romão TT. Macedo YS. et al. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy. 2020. Eur J Neurol. 2020; 27:1748-1750.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Sağlık Kurumları Yönetimi
Bölüm
Olgu Sunumu
Yazarlar
Göktuğ Demirci
*
0000-0002-5079-4713
Türkiye
Yayımlanma Tarihi
25 Aralık 2021
Gönderilme Tarihi
23 Haziran 2021
Kabul Tarihi
8 Aralık 2021
Yayımlandığı Sayı
Yıl 2021 Cilt: 5 Sayı: 3